AR and central nervous system cancer: Further analysis of AR RNA amplification from several datasets, including the TCGA dataset, with OncomineTM software (Compendia Bioscience, Ann Arbor, MI, USA), validated the RNA results (Figure 1B-1C) and showed that AR-RNA is overexpressed also in low-grade gliomas (Figure 1D).